# FDG PET/CT in Lung Cancer Staging

> **NCT02738398** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer (NSCLC)

## Interventions

- **RADIATION:** FDG PET/CT

## Key facts

- **NCT ID:** NCT02738398
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2026-01-27
- **Final completion:** 2026-01-27
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738398, "FDG PET/CT in Lung Cancer Staging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02738398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*